Leaflet CYTOTECT CP BIOTEST 100U / ml solution for infusion

Indicated for: immunosuppression

Route of administration: infusion

Substance: human anti-cytomegalovirus immunoglobulin (immunoglobulin)

ATC: J06BB09 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Human anti-cytomegalovirus immunoglobulin is a plasma-derived product used to prevent or treat cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as transplant recipients. It provides passive immunity by supplying specific antibodies against CMV.

The medication is administered via intravenous injection under the supervision of a specialist.

Side effects may include fever, chills, headache, or infusion site reactions. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should be closely monitored during administration and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about CYTOTECT CP BIOTEST 100U / ml

  • Substance: human anti-cytomegalovirus immunoglobulin
  • Date of latest medicines list: 01-06-2026
  • Product code: W69368002
  • Concentration: 100U / ml
  • Pharmaceutical form: solution for infusion
  • Quantity: 1
  • Product type: Original
  • Price: 4856.61 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: BIOTEST PHARMA GMBH - GERMANIA
  • Holder: BIOTEST PHARMA GMBH - GERMANIA
  • Number: 14855/2023/02
  • Shelf life: 3 years